U.S. Construction Stock News

NYSE:RXO
NYSE:RXOTransportation

RXO (RXO) Gets A Valuation Reset As Weaker Jobs Data Lifts Growth Stock Outlook

RXO (RXO) is back on traders’ radar after weaker July jobs data reduced expectations for near term Federal Reserve rate hikes, which lifted growth stocks and brought fresh attention to the freight broker’s improving sector backdrop. See our latest analysis for RXO. RXO’s share price has pulled back, with a 30 day share price return of down 18.2%. However, the year to date share price return of 67.3% and 1 year total shareholder return of 42.1% still point to strong underlying momentum as...
NYSE:CC
NYSE:CCChemicals

Chemours (CC) Targets Data Center Cooling With New Opteon Refrigerants

Chemours (NYSE:CC) introduced new Opteon ZE and Opteon 515B refrigerants aimed at data centers and commercial cooling. The products target low global warming potential applications and support sustainability and decarbonization goals. The launch expands Chemours' Opteon portfolio into cooling needs for AI focused data centers and mission critical infrastructure. Consider exploring other companies supplying equipment, materials, and services tied to AI focused cooling and power needs through...
NYSE:AMCR
NYSE:AMCRPackaging

Amcor (AMCR) Stock Looks Fully Priced Despite A 41% Fair Value Gap

Amcor stock has delivered a 17.7% return over the past three years, yet its valuation picture is mixed, with a Discounted Cash Flow (DCF) intrinsic value estimate pointing to sizeable upside while earnings based multiples suggest the shares screen as expensive. Amcor's 17.7% three year return suggests the stock has rewarded patient holders, which makes the current pricing debate more important for anyone considering a new position or adding to an existing one. The key support for Amcor's...
NasdaqGS:INSM
NasdaqGS:INSMBiotechs

Insmed (INSM) Is Up 34.2% After Sharp Year-Over-Year Net Loss Reduction - Has The Bull Case Changed?

Insmed Incorporated recently reported second-quarter 2026 earnings, showing a net loss of US$13.24 million versus US$321.69 million a year earlier, and a basic and diluted loss per share from continuing operations of US$0.06 versus US$1.70. For the first half of 2026, Insmed’s net loss narrowed to US$176.81 million from US$578.27 million, highlighting a sharp reduction in per-share losses that may influence how investors assess its path toward financial sustainability. With Insmed’s...
NYSE:CHE
NYSE:CHEHealthcare

Chemed (CHE) Could Be 30% Undervalued As A 17% Dividend Rise Turns Heads

Chemed (CHE) recently announced a 17% increase to its quarterly cash dividend to US$0.70 per share, which highlights management's confidence in the business and draws fresh attention to the stock's income profile. See our latest analysis for Chemed. Alongside the higher dividend, Chemed's recent share price momentum has been strong, with a 30 day share price return of 9.94% and a 90 day share price return of 26.67%. The 1 year total shareholder return of 21.70% and 5 year total shareholder...
NYSE:CF
NYSE:CFChemicals

Did CF’s Q2 Profit Surge and US$500 Million Buyback Just Shift Its (CF) Investment Narrative?

In August 2026, CF Industries Holdings, Inc. reported that second‑quarter sales rose to US$2,222 million and net income climbed to US$727 million, while completing a US$500 million share repurchase program that retired 5,332,201 shares, or 3.41% of its outstanding stock. The sharp jump in earnings per share alongside sizable buybacks highlights how CF Industries is pairing strong current profitability with active capital return, reshaping how investors may interpret its earnings power per...